| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Presentation > Dealing With Difficult Participants - The Nightmare Participant |
|
Useful Advices - Dealing With Difficult Participants - The Nightmare Participant
We have all had them haven’t we? If you’ve done training you’ve had someone who’s disruptiv According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e, possibly rude, pays no attention to you! If I’m totally honest, this type of participant ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in used to upset me a fair bit when I first began training, there was me giving the performanc lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e of my life (!) And there was this smart alec trying to argue with me for arguments sake, c here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hatting to the person next to them and generally being obnoxious! Luckily, I’ve only encoun d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tered two or three like this in my training lifetime but I feel the need to share you a nice ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc little strategy to sort this blemish on a near perfect training life! Firstly remember tha easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t these people are crying out for attention, it’s not personal to you. Martin Luther king c nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ould be standing up there and they’d probably still try it on! They want to look good in fr and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ont of the group, so try and do this: Send the group on a break, and ask for a quick word w ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ith the offender. Say that you worried about the tension between you and the offender and ap ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ologise if you have done anything to upset them, but you don’t want anything to come between dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the groups learning and if they could leave any “challenges” to the end/kerb their behaviou cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin r (add your own or delete as appropriate). This should do the trick, it’s always worked for tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen me, you’ve marked their card in a nice way and shown that you won’t stand for it. Now, if t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the behaviour continues, which it shouldn’t, try this: During an exercise (you do exercises ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust don’t you??!) Take the offender to one side and ask them to leave. There is no point in ri y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sking the entire learning of the group due to one. Also ask them to explain to their manage . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r why they have been asked to leave (Have a word with their manager afterward if at all poss elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ible). Never get yourself a reputation as a trainer who puts up with this sort of nonsense. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Take Ownership of Your Job Search A Troubled Company Cannot Do a Quick Fix by Marrying Another Problematic One
|